These results provide a mechanistic framework for understanding the detailed catalytic behavior of an important subset of the histone acetyltransferases and have significant implications for molecular regulation of and inhibitor design for these enzymes.
Histone acetyltransferases (HATs) 1 appear to modulate gene expression by catalyzing targeted acetylation of the ⑀-amino group of lysine residues on histones and other proteins (1) (2) (3) . Several families of HATs have recently been identified including GCN-5, SRC-1, p300, and TAF250 (1, 2) . Among the more exciting aspects of this emerging field is the recognition that protein substrates for HATs extend outside of the histone family and include such key transcription factors as p53 (4 -6), human immunodeficiency virus TAT (7, 8) , TFIIF␤ (9), GATA-1 (10), and MyoD (11) . Despite their importance, the molecular bases for substrate recognition and the catalytic mechanisms of the group of HAT enzymes have not been established. In this study we focus our attention on the histone acetyltransferase p300/CBP-associated factor (PCAF) (3, 12) . PCAF is a member of the GCN-5-related N-acetyltransferases (GNAT) superfamily that includes a variety of acetyltransferase enzymes such as serotonin N-acetyltransferase, gentamicin N-acetyltransferase, GCN-5, spermidine N-acetyltransferase, HAT 1, and approximately 150 other "motif A/B" acetyltransferases in the DNA sequence data base (13) (14) (15) (16) . Of these superfamily members, the most well characterized mechanistically is serotonin N-acetyltransferase. It was shown to follow an ordered BiBi ternary complex mechanism where acetyl-CoA binds first, most likely with direct attack of the serotonin amine nitrogen on acetyl-CoA (17, 18) . By using viscosity experiments, the rate-determining step appears to be product release (19) . Moreover, serotonin N-acetyltransferase appears to bind the substrate as the protonated (ammonium) species, and nucleophilicity of the amine seems to be important (19) . The sequence homology among the superfamily members is relatively weak, and significant differences exist among their three-dimensional structures (13) (14) (15) (16) . Consequently, how related the serotonin N-acetyltransferase catalytic mechanism will be to that of other superfamily members is unclear.
PCAF was discovered in 1996 as a histone acetyltransferase that interacts with the transcriptional coactivator p300, which is also a HAT (12, 20, 21) . PCAF is a 90-kDa protein that contains several domains as outlined in Fig. 1 . A high resolution x-ray structure of the PCAF HAT domain in a complex with acetyl-CoA shows the conserved structural features of the GNAT superfamily (22) . Functions for the other PCAF domains including the bromodomain (23) are not yet understood, but they may mediate protein-protein interactions or alternatively allosterically regulate PCAF HAT activity.
PCAF has been shown to catalyze highly selective acetylation of lysine 14 of histone H3 both in free histones and nucleosomes (24) . To date, there has been little detailed evaluation of the catalytic mechanism of PCAF. In this report, we reveal several new aspects of the catalytic mechanism of and substrate recognition by PCAF using purified recombinant enzyme and a synthetic peptide substrate. We also describe a detailed analysis of the inhibition of PCAF by a potent and selective bisubstrate analog inhibitor (25) .
MATERIALS AND METHODS
General-Unlabeled acetyl-CoA was purchased from Amersham Pharmacia Biotech; desulfo-CoA, acetylated BSA, and trypsin were obtained from Sigma. Other reagents were obtained from commercial sources unless otherwise described. Full-length PCAF was overproduced and purified as described previously (24) . H3-CoA-20 was prepared as described previously (25) . Mass spectrometry experiments were performed on either a Perkin-Elmer Biosystems API150EX electrospray single quadrupole instrument or a Kratos Kompact MALDI4 (Manchester, UK) time-of-flight mass spectrometer. HPLC was done on Varian instruments with Varian reverse phase HPLC columns.
PCAF cat Production and Purification-The production of PCAF cat was carried out analogously to that described by Marmorstein and colleagues (22) . Briefly, the human PCAF catalytic domain (amino acid residues 493-676) DNA was subcloned into a modified pET28a vector (confirmed by DNA sequencing), engineered so that the His 6 tag could be cleaved by TEV protease (Life Technologies, Inc.), and the protein was overproduced in the Escherichia coli strain BL21DE3 (14) . A frozen permanent cell line was used to inoculate 2 ϫ 30 ml of Luria broth in Erlenmeyer flasks containing kanamycin (25 g/ml) and allowed to grow overnight at 37°C in a floor shaker. This culture (10 ml) was used to inoculate each liter of Luria broth (total 6 liters) in flasks with kanamycin (25 g/ml) and grown at 37°C in a floor shaker until the A 595 ϭ 0.5-0.6. The flasks were cooled to room temperature by standing at 4°C for 15 min and then induced with isopropyl-1-thio-␤-D-galactopyranoside (0.2 mM final concentration). The culture was grown overnight in a floor shaker at 16°C for approximately 20 h. The cells were pelleted by centrifugation (4°C, 5000 ϫ g, 5 min) and then resuspended in 20 ml of lysis buffer (50 mM NaHepes, pH 7.0, 500 mM NaCl, 5 mM dithiothreitol, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride). The suspension was lysed by passage through a French pressure cell at 15,000 pounds/square inch. The insoluble protein and debris were removed by centrifugation (4°C, 27,000 ϫ g, 30 min followed by 4°C, 100,000 ϫ g, 120 min), and the supernatant was quick frozen in liquid nitrogen and stored at Ϫ80°C. The thawed solution was passed through 20 ml of chelating Sepharose resin (30 ml of suspension, washed with 60 ml of water, followed by 100 ml of 50 mM ZnSO 4 solution, and finally equilibrated by washing with 60 ml of IMAC 30 (20 mM NaHepes, pH 7.0, 1 M NaCl, 30 mM imidazole, 1 mM phenylmethylsulfonyl fluoride)) in a 60-ml column packed with the aid of a peristaltic pump at a rate of 0.5-1 ml/min. The loaded resin was washed first with 80 ml of washing buffer A (20 mM NaHepes, pH 7.0, 1 M NaCl, 72.5 mM imidazole, 1 mM phenylmethylsulfonyl fluoride) and then with 80 ml of washing buffer B (20 mM NaHepes, pH 7.0, 1 M NaCl, 98 mM imidazole, 1 mM phenylmethylsulfonyl fluoride). Fractions of 10 ml were collected as the protein was eluted off with ϳ60 ml of IMAC-EDTA buffer (20 mM NaHepes, pH 7.0, 1 M NaCl, 10% glycerol, 200 mM imidazole, 100 mM EDTA). The PCAF cat -containing fractions (as determined by 12% SDS-PAGE) were combined and dialyzed overnight at 4°C (M r 10,000 cut-off) against 1 liter of solution of 50 mM NaHepes, 250 mM NaCl, and 5 mM dithiothreitol. The dialyzed protein solution (volume ϭ 65 ml) was treated with TEV protease (0.1 mg/ml final concentration) at 16°C overnight. The excised His 6 tag was removed by passing the protein solution through 20 ml of chelating Sepharose resin (loaded with 100 ml of 50 mM ZnSO 4 ) and washing the resin with 30 ml of IMAC-30 (20 mM NaHepes, pH 7.0, 1 M NaCl, 30 mM imidazole, 1 mM phenylmethylsulfonyl fluoride) and then 50 ml of IMAC-200 (20 mM NaHepes, pH 7.0, 1 M NaCl, 200 mM imidazole, 1 mM phenylmethylsulfonyl fluoride). The fractions containing the purified PCAF cat (Ͼ90% pure by Coomassie-stained SDS-PAGE) were combined and dialyzed against 1-liter solution of 25 mM NaHepes, pH 7.0, 100 mM NaCl, 1 mM EDTA, and 10 mM dithiothreitol overnight at 4°C. The solution was concentrated to a final volume of 20 ml (2.1 mg/ml as determined by Bradford assay) by Centricon ultrafiltration and then stored at Ϫ80°C.
Peptide Synthesis-Peptides were synthesized on an automated solid phase peptide synthesizer (Rainin, PS3) using the Fmoc (N-(9-fluorenyl)methoxycarbonyl) strategy and purified by preparative C-18 reversed phase HPLC (using a gradient of H 2 O:CH 3 CN:0.05% trifluoroacetic acid). H3-CoA-12 was prepared analogously to H3-CoA-20 according to previously described procedures (25) . All synthetic peptides appeared Ͼ95% pure by HPLC, and their structural identities were confirmed by electrospray mass spectrometry.
Acetyltransferase Activity Assays-HAT kinetic assay procedures were adapted from previously described methods (12, 20, 24, 25) . Briefly, substrate concentrations were 0.5-20 M acetyl-CoA (NEN Life Science Products, 14 C, 0.02 Ci/l), 5-120 M peptide, and buffer conditions included 50 mM Tris-HCl, pH 8, 1 mM dithiothreitol, 0.1 mM EDTA, and 50 g/ml acetylated bovine serum albumin. Reactions employed purified recombinant full-length PCAF or PCAF cat at concentrations of 0.1-100 nM as needed. Assays were carried out in 0.5-ml plastic tubes at 30°C, and the reaction volumes were 30 l. Reactions were initiated with enzyme or acetyl-CoA after allowing the other components to equilibrate at 30°C, and reactions were quenched after 1-10 min with 6 l of 6ϫ SDS-PAGE loading buffer. Mixtures were run out on 16% SDS Tris-Tricine polyacrylamide gels, dried, and radioactivity quantified by phosphorimage analysis (Molecular Dynamics) by comparing to known quantities of 14 C-labeled bovine serum albumin standard (NEN Life Science Products). In all cases, background acetylation (in the absence of enzyme) was subtracted from the total signal. All assays were performed at least twice and duplicates generally agreed within 20%. Enzyme activities were demonstrated to be linear versus enzyme concentration and time in the ranges used. Rate measurements were based on initial conditions (less than 10% consumption of the limiting substrate).
Comparison 
by using a non-linear least squares approach (Macintosh computer program-Kaleidograph TM ), and the kinetic constants Ϯ S.E. are reported in Table I .
Two-substrate Kinetic Measurements with PCAF cat -Two-substrate kinetic analysis was performed with substrate concentrations given in Fig. 3 , and the data were fitted to the sequential (ternary complex) mechanism Equation 2 below using the computer program KinetAsyst II TM (IntelliKinetics) based on the algorithms of Cleland (26),
by using a non-linear least squares approach. Kinetic constants Ϯ S.E. are shown in Table II . K ma ϭ K m of acetyl-CoA in this work; K ia ϭ dissociation constant for acetyl-CoA (dissociation constant to free enzyme where acetyl-CoA binds prior to H3-20), K mb ϭ K m of H3-20.
Fitting to a ping-pong mechanism gave a significantly larger sum of squares of the residuals.
Steady-state Kinetic Measurements with Inhibitors-Competitive inhibition kinetic analysis was done by fitting all of the data points to the linear competitive inhibition Equation 3 of KinetAsyst II
TM based on the algorithms of Cleland (26),
by using a non-linear least squares approach. The fixed substrate was assumed to be saturating. Kinetic constants Ϯ S.E. are shown in Table  III .
Noncompetitive inhibition kinetic analysis was done by fitting all of the data points to the linear noncompetitive inhibition Equation 4 of KinetAsyst II TM based on the algorithms of Cleland (26) 
by using a non-linear least squares approach. Kinetic constants Ϯ S.E. are shown in Table III .
Uncompetitive inhibition kinetic analysis was done by fitting all of the data points to the linear uncompetitive inhibition Equation 5 of KinetAsyst II TM based on the algorithms of Cleland (26),
by using a non-linear least squares approach. Kinetic constants Ϯ S.E. are shown in Table III . The abbreviations are K ii ϭ K i intercept and K is ϭ K i slope based on double-reciprocal plot analysis according to the nomenclature of Cleland (26, 27) . The data for individual experiments with each inhibitor versus a varied substrate was fit to all three inhibitor models. Choice of kinetic fit was based on a combination of visual inspection and comparison of standard errors and residuals for all three inhibition types applied to the data sets (26) . The lines drawn through the data points in the figures are derived from the fitted equations above.
Calculation of k diss -Data for the dissociation rate constant (k diss ) for the bisubstrate analog H3-CoA-20 were fitted to Equation 6 ,
where P is the concentration of acetylated product; v s is the steady-state velocity; k diss is the off rate for the inhibitor from the enzyme, and t is time (28, 29) . Viscosity Experiments-Microviscosity was adjusted by varying the concentration of the microviscogen sucrose as described previously (19, 30) . There were no significant changes in K m values of acetyl-CoA or H3-20 at the extremes of viscosity evaluated.
Mapping the Acetylation Site on H3-20 -PCAF cat acetylation of H3-20 was carried out on a preparative scale as follows: 300 M H3-20, 300 M acetyl-CoA, 1 M PCAF cat , 5 mM phosphate (pH ϳ7.5) mixed in 1 ml and incubated for 10 min at 30°C. The reaction mixture was injected immediately on to a preparative HPLC (C-18 reversed phase column) and separated using a H 2 O, CH 3 CN, 0.05% CF 3 CO 2 H gradient that showed predominantly one peak (Ͼ90%). The resultant product was lyophilized to dryness. The reaction product was analyzed by mass spectrometry. A peak consistent with the monoacetylated H3-20 peptide (ϩ42 Da) was observed.
Tryptic digestion of both the unmodified H3-20 and acetylated H3-20 peptide were examined by MALDI-TOF mass spectrometry. Tryptic digestions were performed by combining 2 l of trypsin (1.0 g/l), 2 l of peptide solution (control peptide, 100 pmol/l; acetylated peptide, 25 l of distilled water was added to dry sample) and 2 l of buffer solution (25 mM ammonium bicarbonate, pH 8). The above reaction mixture (0.3 l) was applied to the sample plate followed by 0.3 l of the saturated ␣-cyano-4-hydroxycinnamic acid matrix solution (1:1 (v/v) ethanol:water). The matrix was added in timed increments (1, 5, 10 , and 60 min) and served to quench the enzymatic digestion. The mixture was allowed to air-dry (10 min) prior to introduction into the mass spectrometer. This product and an equivalent amount of unreacted H3-20 peptide were subjected to trypsin digestion followed by analysis using MALDI mass spectrometry (31) . Comparison of the tryptic fragments led to the unequivocal identification of Lys-14 as the site of acetylation.
RESULTS

H3-20 as a PCAF Substrate-Previous
work has shown that a bisubstrate analog based on the amino-terminal sequence of histone H3 is a potent inhibitor of full-length PCAF (25) . In that study, it was observed that H3-CoA-20 (Fig. 2) , a peptide CoA conjugate with the 20 amino-terminal residues of histone H3, was a potent PCAF inhibitor (IC 50 ϳ 0.3 M), whereas H3-CoA-7 was a comparatively weak inhibitor (IC 50 Ͼ 50 M) (25) . Recently, an x-ray structure of the PCAF homolog was reported in which an 11-amino acid peptide co-crystallized with . Consequently, the 12-residue peptide-CoA conjugate (H3-CoA-12) was prepared, but this too was found to be only a weak PCAF inhibitor (IC 50 ϳ50 M). From this finding, it was deduced that greater than 12 residues but less than or equal to 20 residues are likely necessary for high affinity binding.
We thus investigated the corresponding unmodified H3-related peptide (H3-20) as a PCAF substrate. As with the previously described histone acetylation assay, [
14 C]acetyl-CoA was used as substrate, and radioactive 14 C incorporation into the peptide product was determined. Separation and quantification was achieved using a 16% Tris-Tricine SDS-PAGE followed by phosphorimage analysis. In this way, it was found that H3-20 afforded a reasonably sharp band (data not shown) that was readily quantified. Furthermore it was found that, unlike with the case of histones, PCAF enzyme activity was linear with respect to both enzyme concentration (0.5-5 nM range) and time (up to 10 min). It was therefore possible to measure k cat (0.7 s Ϫ1 ) and K m values for acetyl-CoA (2.1 M) and H3-20 (10 M) (see Table I ).
Given the difficulty in obtaining large quantities of fulllength PCAF from eukaryotic expression systems, we turned to the study of recombinant PCAF catalytic domain (PCAF cat ) that was overproduced in E. coli (22) . PCAF cat was inhibited by H3-CoA-20 with a similar IC 50 to full-length PCAF (data not shown). Steady-state kinetic studies showed that it had similar but non-identical parameters using H3-20 peptide as substrate. In particular for PCAF cat , the apparent k cat was approximately 4-fold greater, the apparent K m for H3-20 substrate was about 3-fold higher, and the apparent K m for acetyl-CoA was about 3-fold lower compared with full-length PCAF (see Table I ). Because of the relatively small magnitude of the differences, we felt confident that mechanistic and substrate selectivity parameters determined for PCAF cat HAT activity would likely be relevant for full-length PCAF. The experiments described below were therefore carried out with PCAF cat .
PCAF cat HAT Assays with H4-20 -In order to quantitatively assess the selectivity of PCAF for H3-20, H4-20 was evaluated as a PCAF cat substrate. H4-20 is a peptide derived from the first 20 amino-terminal residues of histone H4 (25) , and it has been reported for the full-length proteins that histone H4 is less efficiently acetylated compared with histone H3 (24) . As expected, H4-20 was a much weaker PCAF cat substrate than H3-20. Acetylation showed somewhat complex kinetics (data not shown) and was not amenable to a simple Michaelis-Men- ten fit. However, direct comparison of acetyltransferase rate at 80 M of both peptide concentration shows that H3-20 is processed ϳ500-fold faster than H4-20.
Mapping the H3-20 Acetylation Site-In order to map the acetylation site of H3-20, a mass spectrometric approach was applied. A mass increase of 42 daltons from the unmodified peptide indicated the addition of a single acetyl group. The acetylated peptide was treated with trypsin and produced a number of tryptic fragments. This digestion mixture was then analyzed directly by MALDI-TOF mass spectrometry and served to map the location of the acetyl group. The peptide map showed that the acetylated residue of H3-20 was Lys-14.
PCAF cat HAT Assays with H3-20 K14A-To confirm and quantitate the site selectivity of H3-20 for Lys-14 and to develop a dead-end analog inhibitor for the steady-state kinetic analysis below, H3-20 K14A was synthesized and evaluated as a substrate for PCAF cat HAT activity. As expected, H3-20 K14A was a very weak substrate for PCAF cat . Although precise k cat and K m values were difficult to measure with this peptide substrate because of its low activity, a direct comparison of rates for acetylation of 100 M of both substrates showed that H3-20 K14A was processed ϳ200-fold slower than H3-20 itself.
Two-substrate Kinetic Studies with PCAF cat -In order to establish that PCAF follows a ternary complex mechanism as opposed to a ping-pong kinetic mechanism, we examined the effects of varying the concentrations of both acetyl-CoA and H3-20 on the acetyltransferase rate (Fig. 3) . As can be seen from the double-reciprocal plot, a clear intersecting line pattern is observed consistent with a ternary complex mechanism. The K m , K i , and k cat values (see Table II ) obtained by a global fit of the data are in reasonable agreement (within 2-fold) with those apparent values obtained for PCAF cat at fixed second substrate concentrations as described above.
Inhibition of PCAF cat by Desulfo-CoA-In order to determine the order of binding of the two substrates for catalysis, inhibition experiments were initiated with desulfo-CoA, a dead-end analog of acetyl-CoA. Desulfo-CoA was clearly shown to be a linear competitive inhibitor of the PCAF cat HAT reaction versus varying concentration of acetyl-CoA with K is ϭ 0.57 M (Fig. 4 and Table III) . The low K i value suggests that the acetyl carbonyl group of acetyl-CoA likely contributes little to binding. In contrast, desulfo-CoA exhibited a linear noncompetitive pattern versus varying H3-20 concentration (Fig. 4) . Although in this case the fit was significantly better for noncompetitive versus uncompetitive inhibition, the K is was about ϳ5-fold higher than the K ii (Table III) . This suggests significant binding synergy between desulfo-CoA and H3-20 and that enzyme inhibition by desulfo-CoA is enhanced by the peptide substrate. The noncompetitive inhibition pattern suggests that binding of acetyl-CoA either precedes H3-20 or that substrate binding is random. It effectively rules out obligatory ordered binding of peptide substrate prior to acetyl-CoA for catalytic turnover. Table III . Inhibition of PCAF cat by H3-20 K14A-The peptide H3-20 K14A was employed as a dead-end analog of the peptide substrate to determine its apparent affinity as well as to dissect further the kinetic mechanism. H3-20 K14A was found to be a linear competitive inhibitor versus varying H3-20 concentrations ( Fig. 5 and Table III Inhibition of PCAF cat by H3-CoA-20 -In previous work, it was shown that H3-CoA-20 exhibited potent inhibition versus acetyl-CoA, but the mode of inhibition was not determined. In principle, H3-CoA-20 could exhibit "slow binding" behavior of PCAF cat as is common for tight binding inhibitors. We thus investigated carefully the time course of inhibition. In the presence of H3-CoA-20, the rate of the PCAF cat -catalyzed reaction was linear within 20 s after initiation, and the slope did not change with increasing time (data not shown). This suggests that binding of the inhibitor to the enzyme and/or conformational changes necessary to reach maximal inhibition are achieved relatively rapidly compared with the time scale of the assay.
To assess the dissociation rate of H3-CoA-20 from PCAF cat , an experiment was performed in which the fully inhibited enzyme (0.5 M PCAF cat , 10 M H3-CoA-20) was rapidly diluted 150-fold into a solution containing near-saturating concentrations of acetyl-CoA and H3-20 to minimize the inhibitory effect (Ͻ20%) of H3-CoA-20 on PCAF cat after initial dissociation from the enzyme. In this way, it was shown that there was a slight lag phase in product formation before the steady-state rate was reached (Fig. 6) . In control experiments in the absence of inhibitor, no lag phase is apparent (data not shown) ruling out an artifact of mixing as the source of this lag. This lag phase was interpreted therefore as the time course for inhibitor dissociation from PCAF cat . The extrapolated dissociation rate constant (k diss ) was shown to be 0.028 s Ϫ1 . Given the relatively fast dissociation rate and the fast "on rate" for H3-CoA-20 with PCAF cat , a steady-state inhibitor analysis was feasible. In these experiments, H3-CoA-20 was shown to be a linear competitive inhibitor versus varying acetyl-CoA concentration (K is ϭ 28 nM) and a linear noncompetitive inhibitor versus varying H3-20 concentration (Fig. 7 and Table III ). This pattern of inhibition is most consistent with an ordered BiBi sequential kinetic mechanism (18) .
Viscosity Effect on the PCAF cat Acetyltransferase Reaction-In order to investigate the nature of the rate-limiting step, the effects of sucrose microviscosity on the steady-state kinetic parameters were measured. At the highest relative viscosity ratio tested, the K m values for acetyl-CoA or H3-20 were not appreciably affected (data not shown). A plot of the k cat Ϫ control/k cat Ϫ viscogen versus relative viscosity ratio showed only a minimal positive slope of 0.03 (Fig. 8) . The viscosity effect on the GNAT superfamily member serotonin N-acetyltransferase (slope ϭ ϩ0.75) is shown for comparison. This lack of a microviscosity effect argues against diffusional release of products being rate-determining for the PCAF cat reaction. DISCUSSION A detailed understanding of the catalytic mechanism and substrate selectivity of HAT enzymes is an important component of defining the molecular basis of their biological functions. Furthermore, such understanding is likely to enhance Table III . the design of potent and selective HAT inhibitors. Prior to this investigation, a preliminary mechanistic analysis on the HAT enzyme GCN-5 was reported. In this study, mixed histone substrates were used as the acetyl-CoA acceptor (33) . Whereas this study revealed an intersecting line pattern for GCN-5 suggestive of a ternary complex mechanism, more detailed studies investigating order of substrate binding were not described. The complexity of the mixed histone substrate may have made detailed mechanistic studies difficult. In our hands, PCAF does not show linearity in plots of enzyme activity versus time or enzyme concentration using mixed histone substrates. Furthermore, high background acetyltransferase activities accompany these mixed histone preparations that also complicate kinetic studies.
In the current analysis, a short 20-amino acid peptide sequence taken from the amino terminus of histone H3 was employed as a PCAF substrate. The length of this sequence was based on previous and current data showing that H3-CoA-20 was a potent bisubstrate analog, whereas H3-CoA-7 and H3-CoA-12 were weakly inhibitory. Unlike mixed histones, this peptide displayed classical steady-state kinetic behavior as a substrate, which made it most useful for kinetic studies. Among the first experiments carried out with this peptide substrate was the measurement of the apparent k cat and K m values for acetyl-CoA and peptide. It should be mentioned that these values (Table I) The catalytic domain of PCAF (PCAF cat ) showed comparable histone acetyltransferase kinetic parameters to the full-length enzyme, validating the utility of PCAF cat for further kinetic experiments. It also suggests that all of the key recognition elements for peptide substrate selectivity are present in the PCAF catalytic domain, and the non-catalytic PCAF domains do not contribute much to this recognition. This is not meant to imply that protein substrate recognition by PCAF would not be influenced by the non-catalytic domains of PCAF. For example, a 25-amino acid peptide derived from the known acetylation site of p53 is a very weak PCAF (full-length), and PCAF cat substrate (k cat /K m is reduced ϳ10,000-fold compared with H3-20), 2 and it appears likely that the molecular recognition of p53 by PCAF will involve more complex interactions if it is physiologically relevant. As p53 is acetylated in a DNA damage-dependent manner in cultured cells (6) , the binding mode of PCAF to p53 might be regulated via a signaling network.
The known selectivity of PCAF for Lys-14 of histone H3 was demonstrated for the peptide substrate H3-20 by showing that the corresponding K14A-substituted peptide was a very poor PCAF substrate and that a similar length peptide derived from histone H4 (H4-20) was also a poor substrate. Furthermore, the specificity was confirmed by mass spectrometric analysis of PCAF cat -mediated acetylation of H3-20 that indicated a single acetylation event on Lys-14 had occurred. 2 O. Lau, unpublished data. Acetyltransferase assays and data fitting were performed as described under "Materials and Methods." The inhibition parameters are displayed in Table III . Rates were analyzed after 4-min reaction times to ensure the measurement of steady-state kinetic constants. In order to confirm the expected ternary complex mechanism for this GNAT family member, a steady-state kinetic analysis was undertaken where both substrate concentrations were varied within the same experiment. These results showed a clear intersecting line pattern, consistent with a sequential (ternary complex) mechanism and disfavoring a ping-pong mechanism. Inhibition studies with the dead-end analog inhibitors desulfoCoA and H3-20 K14A established an ordered BiBi kinetic mechanism in which acetyl-CoA binding precedes peptide binding. The kinetics of inhibition of PCAF cat by the bisubstrate analog H3-CoA-20 were also confirmatory of the ordered BiBi kinetic mechanism.
The finding that PCAF obeys a sequential ordered BiBi kinetic mechanism is similar to the previous results with the GNAT superfamily member serotonin N-acetyltransferase (17, 18) , despite their wide amino acid sequence divergence. Although not rigorously evaluated with other GNAT superfamily members, it seems plausible that this will be the rule for the superfamily. A key loop movement in serotonin N-acetyltransferase has been suggested to be the structural basis for ordered binding (34) in that enzyme and analogous conformational changes likely explain the ordered binding in PCAF. Establishing this mechanism may have significant implications for HAT regulation and inhibitor design. For example, the presumed conformational change associated with acetyl-CoA binding may impact upon interactions with other proteins in transcriptional complexes. Likewise, the stability of the protein may be modulated by alterations in acetyl-CoA concentration (35) . Moreover, it is likely that peptide substrate inhibitor analogs would require the initial binding of acetyl-CoA (or a CoA analog) in order to potently inhibit PCAF. The fluctuations in concentrations of acetyl-CoA in the cell could therefore cause variations in inhibitor potency in vivo. This makes the bisubstrate analog approach to inhibitor design particularly appealing for PCAF.
The bisubstrate analog H3-CoA-20 is a potent inhibitor of PCAF cat (K is ϭ 28 nM). However, since the K i of desulfo-CoA is ϳ600 nM, this suggests that the attachment of the H3-20 peptide only provides approximately a factor of 20-fold in enhanced affinity (additional binding energy of 1.7 kcal/mol) compared with desulfo-CoA. Since bisubstrate analogs can in optimal cases provide additive binding energy (or greater) compared with the binding energy of the individual substrates, a theoretical K i less than 1 nM might have been anticipated for H3-CoA-20. Indeed, the bisubstrate analog for the related enzyme serotonin N-acetyltransferase displayed a K i (91 nM) that was equivalent to the sum of the expected binding energy for both substrates (K m(app) tryptamine ϭ 0.26 mM, K m(app) for acetyl-CoA ϭ 0.36 mM) (18) . Why this is not the case for H3-CoA-20 and PCAF is unclear, but one possibility is that the acetyl bridge in H3-CoA-20 between the two substrate moieties is not ideal for PCAF binding. Future objectives will involve optimizing this tethering functionality as well as exploring approaches to enhance the cell permeability of potent analogs (29) .
The results of the viscosity effect studies also differ between serotonin N-acetyltransferase and PCAF. Whereas product release appears to be rate-limiting in the former case, with PCAF it seems that the rate-determining step is likely to be the chemical step. The overall PCAF k cat is approximately 10-fold lower compared with that of serotonin N-acetyltransferase (17) . Furthermore, for the true PCAF substrate, nucleosomes, it is likely that the catalytic rate constant is slower still (25) . Perhaps the plodding catalytic rate of PCAF histone acetylation is biologically advantageous because the state of histone acetylation has to be finely tuned to prevent the critical consequences of dysregulated gene expression.
